Peter Kaiser, MD
Otolaryngology · Phoenix, AZNPI 1609872894
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $113,701 of the $114,425 with a category attached, or 99.4%. Ocular Therapeutix, Inc. accounts for 97.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $111,124 and has fallen 100.0% since, to $21 in 2025. Among otolaryngology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $5721.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ocular Therapeutix, Inc.$111K
- Alnylam Pharmaceuticals Inc.$3K
- Stryker$564
- Aerin Medical Inc.$90
- Optinose US, Inc.$38
- Regeneron Healthcare Solutions, Inc.$19
- plus $13 from 1 others
What the payments were for
- Consulting fees$113,70199%
- Food & beverage$7241%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ocular Therapeutix, Inc. | 1 | $110,971 |
| Alnylam Pharmaceuticals Inc. | 1 | $2,730 |
| Stryker | 11 | $564 |
| Aerin Medical Inc. | 3 | $90 |
| Optinose US, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$114,425 in reported general payments places this provider in the 95th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 122 | $3,003 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 31 | $1,584 |
| Fluticasone Propionate | 97 | $1,531 |
| Montelukast Sodium | 135 | $1,100 |
| Fluocinolone Acetonide Oil | 19 | $747 |
| Cephalexin | 27 | $323 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $317 |
| Acetic Acid | 14 | $268 |
| Methylprednisolone | 23 | $194 |
| Mupirocin | 21 | $190 |
| Omeprazole | 15 | $146 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $141 |
| Prednisone | 33 | $125 |
| Ondansetron OdtOndansetron | 21 | $96 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Phoenix
- Farhan TaghizadehPhoenix$46K
- Shawn StevensPhoenix$33K
- Richard PearlsteinPhoenix$10K
- Devyani LalPhoenix$8K
- Christian PaquetPhoenix$8K
- Alyson KaplanPhoenix$6K
- Manikandan SugumaranPhoenix$6K
- Robert BridgePhoenix$6K
- Jeffrey TaffetPhoenix$6K
- Michael GutmanPhoenix$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.